Literature DB >> 33936447

Predicting Type 1 Diabetes Onset using Novel Survival Analysis with Biomarker Ontology.

Ying Li1, Bin Liu1, Vibha Anand2,3, Jessica L Dunne4, Markus Lundgren5, Kenney Ng2, Marian Rewers6, Riitta Veijola3, Mohamed Ghalwash1.   

Abstract

Type 1 diabetes (T1D) is a chronic autoimmune disease that affects about 1 in 300 children and up to 1 in 100 adults during their life-time1. Improvements in early prediction of T1D onset may help prevent diagnosis for diabetic ketoacidosis, a serious complication often associated with a missed or delayed T1D diagnosis. In addition to genetic factors, progression to T1D is strongly associated with immunologic factors that can be measured during clinical visits. We developed a T1D-specific ontology that captures the dynamic patterns of these biomarkers and used it together with a survival model, RankSvx, proposed in our prior work2. We applied this approach to a T1D dataset harmonized from three birth cohort studies from the United States, Finland, and Sweden. Results show that the dynamic biomarker patterns captured in the proposed ontology are able to improve prediction performance (in concordance index) by 5.3%, 3.3%, 2.8%, and 1.0% over baseline for 3, 6, 9, and 12 month duration windows, respectively. ©2020 AMIA - All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33936447      PMCID: PMC8075541     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  22 in total

Review 1.  Epidemiology of type 1 diabetes.

Authors:  David M Maahs; Nancy A West; Jean M Lawrence; Elizabeth J Mayer-Davis
Journal:  Endocrinol Metab Clin North Am       Date:  2010-09       Impact factor: 4.741

Review 2.  Autoantibodies in diabetes.

Authors:  Catherine Pihoker; Lisa K Gilliam; Christiane S Hampe; Ake Lernmark
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

3.  Predicting type 1 diabetes using biomarkers.

Authors:  Ezio Bonifacio
Journal:  Diabetes Care       Date:  2015-06       Impact factor: 19.112

Review 4.  Dysregulation of glucose metabolism in preclinical type 1 diabetes.

Authors:  Riitta Veijola; Maarit Koskinen; Olli Helminen; Anne Hekkala
Journal:  Pediatr Diabetes       Date:  2016-07       Impact factor: 4.866

5.  Large-scale parametric survival analysis.

Authors:  Sushil Mittal; David Madigan; Jerry Q Cheng; Randall S Burd
Journal:  Stat Med       Date:  2013-04-28       Impact factor: 2.373

Review 6.  Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention.

Authors:  Aaron Michels; Li Zhang; Anmar Khadra; Jake A Kushner; Maria J Redondo; Massimo Pietropaolo
Journal:  Pediatr Diabetes       Date:  2015-07-23       Impact factor: 4.866

7.  Childhood thyroid autoimmunity and relation to islet autoantibodies in children at risk for type 1 diabetes in the diabetes prediction in skåne (DiPiS) study.

Authors:  Berglind Jonsdottir; Christer Larsson; Markus Lundgren; Anita Ramelius; Ida Jönsson; Helena Elding Larsson
Journal:  Autoimmunity       Date:  2018-08       Impact factor: 2.815

8.  Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom.

Authors:  A Paul Lambert; Kathleen M Gillespie; Glenys Thomson; Heather J Cordell; John A Todd; Edwin A M Gale; Polly J Bingley
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

9.  An ontology-driven, diagnostic modeling system.

Authors:  Peter J Haug; Jeffrey P Ferraro; John Holmen; Xinzi Wu; Kumar Mynam; Matthew Ebert; Nathan Dean; Jason Jones
Journal:  J Am Med Inform Assoc       Date:  2013-03-23       Impact factor: 4.497

10.  Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young.

Authors:  Andrea K Steck; Kelly Johnson; Katherine J Barriga; Dongmei Miao; Liping Yu; John C Hutton; George S Eisenbarth; Marian J Rewers
Journal:  Diabetes Care       Date:  2011-05-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.